Name | 2-[(3R,6E,10E)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione |
---|---|
Synonyms |
Vatiquinone
2-[(3R,6E,10E)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trien-1-yl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione 2-[(3R,6E,10E)-3-Hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl]-3,5,6-trimethyl-1,4-benzoquinone 2,5-Cyclohexadiene-1,4-dione, 2-[(3R,6E,10E)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl]-3,5,6-trimethyl- UNII-6O85FK9I0X EPI-743 Vatiquinone (USAN) |
Description | Vatiquinone is a potent cellular oxidative stress protectant, which could be used to treat mitochondrial diseases. |
---|---|
Related Catalog | |
Target |
Mitochondria[1]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 565.6±39.0 °C at 760 mmHg |
Molecular Formula | C29H44O3 |
Molecular Weight | 440.658 |
Flash Point | 309.9±23.6 °C |
Exact Mass | 440.329041 |
PSA | 54.37000 |
LogP | 9.35 |
Vapour Pressure | 0.0±3.5 mmHg at 25°C |
Index of Refraction | 1.512 |